Spontaneous Breathing Trial With T-piece or Inspiratory Pressure Augmentation
NCT ID: NCT04222205
Last Updated: 2025-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
2143 participants
INTERVENTIONAL
2019-12-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesized that an SBT with inspiratory pressure augmentation increases initial SBT success, reduces the length of invasive mechanical ventilation (iMV) support and does not increase reintubation risk as compared with T-piece, which result in a higher proportion of patients successfully liberated from iMV in the inspiratory pressure augmentation group. However, inspiratory pressure augmentation significantly reduces work of breathing on an SBT as compared with T-piece. Patients extubated following an SBT with inspiratory pressure augmentation may experience increased respiratory effort after extubation and this may increase the use of noninvasive ventilation after extubation. An SBT with inspiratory pressure augmentation increases iMV free days but not MV free days as compared with T-piece. Longer iMV free days may be associated with a lower mortality due to fewer iMV related complication.
This study is a pragmatic, cluster-randomized, multiple crossover, multicenter trial to compare SBTs with T-piece versus inspiratory pressure augmentation in weaning outcomes. Mechanically ventilated patients who meet the criteria for readiness to SBT will be included. The patients will use either T-piece or inspiratory pressure augmentation as SBT for weaning according to an ICU-based cluster randomization and crossover sequence.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extubation With or Without Spontaneous Breathing Trial
NCT01020773
Microcirculation in Spontaneous Breathing Trial
NCT04711590
A SBT-based Protocol-directed Program in Difficult-to-Wean Patients
NCT05035355
T-piece Versus Pressure-support for the Spontaneous Breathing Trial
NCT04227639
Optimal Timing for Spontaneous Breathing Trials
NCT06561295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Crossover sequence 1
Cluster-randomization crossover sequence 1:
T-piece during odd-numbered months and inspiratory pressure augmentation during even-numbered months.
Spontaneous breathing trial (SBT) crossover sequence 1
SBTs with T-piece breathing for one hour during odd-numbered months and SBTs with inspiratory pressure augmentation for one hour during even-numbered months.
Crossover sequence 2
Cluster-randomization crossover sequence 2:
T-piece during even-numbered months and inspiratory pressure augmentation during odd-numbered months.
Spontaneous breathing trial (SBT) crossover sequence 2
SBTs with inspiratory pressure augmentation for one hour during odd-numbered months and SBTs with T-piece breathing for one hour during even-numbered months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spontaneous breathing trial (SBT) crossover sequence 1
SBTs with T-piece breathing for one hour during odd-numbered months and SBTs with inspiratory pressure augmentation for one hour during even-numbered months.
Spontaneous breathing trial (SBT) crossover sequence 2
SBTs with inspiratory pressure augmentation for one hour during odd-numbered months and SBTs with T-piece breathing for one hour during even-numbered months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Receiving invasive mechanical ventilation via an endotracheal tube
3. Ready to start an SBT\* \*The criteria of readiness to an SBT include FiO2 ≤ 0.4, PEEP ≤ 8 cmH2O, minute ventilation ≤ 0.15 L/min/predicted body weight, inspiratory pressure or driving pressure ≤ 14 cm H2O, stable cardiovascular status and no worsening of non-pulmonary organ function.
Exclusion Criteria
2. Receiving mechanical ventilation via tracheostomy
3. Mechanical ventilation \< 12 hours
4. Invasive ventilation started before the index hospitalization
5. On do-not-intubate order
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Fu-Chang Tsai, MD, PhD
Role: STUDY_CHAIR
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, Please Select, Taiwan
National Taiwan University Hospital Hsin-Chu Branch
Taoyuan District, , Taiwan
National Taiwan University Hospital Yunlin Branch
Yunlin, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201901036RINA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.